• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Genetics Market
Genetics News
Genetics Stocks
  • Genetics Market
  • Genetics News
  • Genetics Stocks

U.S. Stem Cell's Chief Science Officer Co-Authors Featured Paper

Written by Bryan Mc Govern
|
Jun. 21, 2017 08:17AM PST

A paper co-authored by Kristin Comella’s, chief science officer for U.S. Stem Cell about an intra-articular injection for the treatment of osteoarthritis in the latest issue of the Journal of Translational Medicine.

A paper co-authored by Kristin Comella’s, chief science officer for U.S. Stem Cell (OTCQB:USRM) about an intra-articular injection for the treatment of osteoarthritis in the latest issue of the Journal of Translational Medicine.
As quoted in the press release:

Comella is a world-renowned expert on regenerative medicine with a focus on adipose derived stem cells. She was named number 24 on Terrapin’s list of the Top 50 Global Stem Cell Influencers and number 1 on the Academy of Regenerative Practices list of Top 10 Stem Cell Innovators. Comella has pioneered stem cell therapies from various sources including cord blood, bone marrow, muscle, and adipose.
Entitled, “Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis,” the scientific paper was co-authored by Kristin Comella, Himanshu Bansal, Jerry Leon, Poonam Verma, Diwaker Agrawal, Prasad Koka and Thomas Ichim. Below is a link and abstract to the paper: https://bit.ly/2smaM93.

Click here to read the full press release.

Source: www.accesswire.com

regenerative medicine stem cells top 10 top 50
The Conversation (0)

Go Deeper

AI Powered
Life Science Outlook: World Edition

Life Science Outlook: World Edition

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Genetics Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES